Actelion Tracleer
Executive Summary
Bosentan tablets will be reviewed by the committee for pulmonary hypertension (NDA 21-290) Aug. 10. The Aug. 9 and 10 meetings will be held at the National Institutes of Health Masur Auditorium in Bethesda, Md., beginning at 8:30 a.m